David Hojnacki

Research activity per year

Fingerprint

Dive into the research topics where David Hojnacki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

5 Finished

BIIB133: A MC, Rand, DB, PC active reference, parallel group, dose ranging Phase 2 eval effic & safety of IV Dapiirolizumab Pegol in relapsing MS
Hojnacki, D. (PI)
Biogen MA Incorporated
01/1/21 → 06/1/22
Project: Research
Plegridy (peginterferon B-1a) Ral World Effectiveness and Safety Observational Program
Hojnacki, D. (PI)
Biogen MA Incorporated
11/16/15 → 11/15/23
Project: Research
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB003 in Subjects with Relapsing Forms of Multiple Sclerosis When Used Concurrently
Hojnacki, D. (PI)
Biogen IDEC
08/1/14 → 07/31/15
Project: Research
A Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects with Multiple Sclerosis Who Have Completed Study 205MS301
Hojnacki, D. (PI)
Biogen IDEC
02/19/14 → 02/18/19
Project: Research
An Open-Label Multicenter Study to Evaluate the Safe and Effective Use of the Single-Use Autoinjector with an Avonex? Syringe in Multiple Sclerosis Subjects
Hojnacki, D. (PI)
Biogen IDEC
04/14/10 → 04/13/12
Project: Research

100 Article
2 Comment/debate
1 Letter
1 Review article

Diffusion tensor imaging along the perivascular space and disease progression in people with multiple sclerosis: a 5-year longitudinal MRI study
Tranquille, A., Zivadinov, R., Weinstock-Guttman, B., Eckert, S. P., Hojnacki, D., Dwyer, M. G. & Bergsland, N., 2026, In: Brain Communications. 8, 1, fcag002.
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations
Dura mater enhancement on 3T MRI is associated with cortical lesion burden in multiple sclerosis
Zivadinov, R., Semy, M., Bartnik, A., Hildesheim, F. E., Tranquille, A., Jakimovski, D., Hojnacki, D., Eckert, S., Weinstock-Guttman, B., Dwyer, M. G. & Bergsland, N., Apr 2026, In: Journal of Neurology. 273, 4, 251.
Research output: Contribution to journal › Article › peer-review

Open Access
Relating perivascular imaging measures to longitudinal lesion evolution and chronic inflammation in multiple sclerosis
Tranquille, A., Bergsland, N., Reeves, J. A., Bartnik, A., Weinstock-Guttman, B., Eckert, S. P., Hojnacki, D., Dwyer, M. G. & Zivadinov, R., Aug 2026, In: Multiple Sclerosis and Related Disorders. 112, 107322.
Research output: Contribution to journal › Article › peer-review
Ultra-low-field MRI for bedside imaging of severe multiple sclerosis
Bergsland, N., Burnham, A., Dwyer, M. G., Bartnik, A., Schweser, F., Kennedy, C., Tranquille, A., Semy, M., Schnee, E., Pol, S., Krawczyk, A., Young-Hong, D., Eckert, S., Hojnacki, D., Reilly, C., Benedict, R. H. B., Weinstock-Guttman, B. & Zivadinov, R., Jun 2026, In: Journal of Neurology. 273, 6, 364.
Research output: Contribution to journal › Article › peer-review

Open Access
Determinants of long-term paramagnetic rim lesion evolution in people with multiple sclerosis
Reeves, J. A., Bartnik, A., Mohebbi, M., Ramanathan, M., Bergsland, N., Jakimovski, D., Wilding, G. E., Salman, F., Schweser, F., Weinstock-Guttman, B., Hojnacki, D., Eckert, S., Bagnato, F., Dwyer, M. G. & Zivadinov, R., Feb 2025, In: Annals of Clinical and Translational Neurology. 12, 2, p. 267-279 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
10 Scopus citations

David Hojnacki

Personal profile

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

BIIB133: A MC, Rand, DB, PC active reference, parallel group, dose ranging Phase 2 eval effic & safety of IV Dapiirolizumab Pegol in relapsing MS

Plegridy (peginterferon B-1a) Ral World Effectiveness and Safety Observational Program

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB003 in Subjects with Relapsing Forms of Multiple Sclerosis When Used Concurrently

A Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of BIIB019, Daclizumab High Yield Process (DAC HYP), Monotherapy in Subjects with Multiple Sclerosis Who Have Completed Study 205MS301

An Open-Label Multicenter Study to Evaluate the Safe and Effective Use of the Single-Use Autoinjector with an Avonex? Syringe in Multiple Sclerosis Subjects

Diffusion tensor imaging along the perivascular space and disease progression in people with multiple sclerosis: a 5-year longitudinal MRI study

Dura mater enhancement on 3T MRI is associated with cortical lesion burden in multiple sclerosis

Relating perivascular imaging measures to longitudinal lesion evolution and chronic inflammation in multiple sclerosis

Ultra-low-field MRI for bedside imaging of severe multiple sclerosis

Determinants of long-term paramagnetic rim lesion evolution in people with multiple sclerosis

David Hojnacki

Personal profile

Fingerprint

Collaborations and top research areas from the last five years

Grants & Projects

Research output